- Home
- VITL vs PRAX Comparison
VITL vs PRAX Comparison
Compare VITL & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VITL
- PRAX
- Stock Information
- Founded
- VITL 2007
- PRAX 2015
- Country
- VITL United States
- PRAX United States
- Employees
- VITL N/A
- PRAX N/A
- Industry
- VITL Packaged Foods
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- VITL Consumer Staples
- PRAX Health Care
- Exchange
- VITL Nasdaq
- PRAX Nasdaq
- Market Cap
- VITL 1.5B
- PRAX 1.4B
- IPO Year
- VITL 2020
- PRAX 2020
- Fundamental
- Price
- VITL $34.90
- PRAX $74.49
- Analyst Decision
- VITL Strong Buy
- PRAX Strong Buy
- Analyst Count
- VITL 9
- PRAX 9
- Target Price
- VITL $41.25
- PRAX $149.00
- AVG Volume (30 Days)
- VITL 1.1M
- PRAX 388.8K
- Earning Date
- VITL 02-27-2025
- PRAX 03-04-2025
- Dividend Yield
- VITL N/A
- PRAX N/A
- EPS Growth
- VITL 151.76
- PRAX N/A
- EPS
- VITL 1.12
- PRAX N/A
- Revenue
- VITL $576,129,000.00
- PRAX $1,605,000.00
- Revenue This Year
- VITL $29.83
- PRAX N/A
- Revenue Next Year
- VITL $18.59
- PRAX N/A
- P/E Ratio
- VITL $31.05
- PRAX N/A
- Revenue Growth
- VITL 29.14
- PRAX N/A
- 52 Week Low
- VITL $16.18
- PRAX $33.01
- 52 Week High
- VITL $48.41
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- VITL 37.11
- PRAX 42.80
- Support Level
- VITL $33.14
- PRAX $76.00
- Resistance Level
- VITL $36.60
- PRAX $91.83
- Average True Range (ATR)
- VITL 1.81
- PRAX 6.29
- MACD
- VITL -0.44
- PRAX -1.10
- Stochastic Oscillator
- VITL 20.18
- PRAX 2.42
About VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.